CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia

Hexian Li; Qizhong Lu; Zhengyu Yu; Zhiguo Wu; Zhixiong Zhu; Jia Li; Zongliang Zhang; Zeng Wang; Nian Yang; Yongdong Chen; Huaqing Lu; Ting Niu; Aiping Tong

doi:https://doi.org/10.1097/cm9.0000000000003588

CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia

Identifier:nobleid.org/w1/20260418/406382BF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/406382BF.svg?ark=w1%2F20260418%2F406382BF)](https://nobleid.org/work/w1/20260418/406382BF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia

Identifier:nobleid.org/w1/20260418/406382BF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/406382BF.svg?ark=w1%2F20260418%2F406382BF)](https://nobleid.org/work/w1/20260418/406382BF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work